Analysis of the cost of isolation treatment and the infection of sputum bacteria in 56 patients with smear positive pulmonary tuberculosis

Abstract

Abstract: Objective To analyze the cost of two weeks' isolation treatment and the change of sputum bacterial infectivity in smear positive pulmonary tuberculosis patients, and to evaluate the mode of isolation treatment and the feasibility of reducing infectivity. Methods From July 2018 to June 2019, 56 patients with smear positive tuberculosis diagnosed by Shenzhen Longgang District chronic disease prevention and control hospital and taking part in isolation treatment in hospital were collected, and the change data of hospitalization cost, sputum smear and sputum bacteria culture were analyzed. Results the average hospitalization days of 56 patients were (15.6 ± 1.5) days, 96.42% (54/56) patients were hospitalized for more than 2 weeks, the average hospitalization cost was 9805 yuan, the negative conversion rate of sputum smear was 48.21% (27/56), the negative conversion rate of sputum culture was 44.64% (25/56), and more than half of the patients were still smear positive and sputum culture positive. Conclusion the cost of isolated hospitalization is heavy, and the measures of isolated hospitalization can only be carried out on the premise of multi-channel financing to solve the cost of isolated hospitalization. Two weeks of isolated hospitalization can reduce the risk exposure of smear positive tuberculosis patients to the surrounding population, but more than half of the patients are still infectious. It is the most appropriate time and exploration for isolated hospitalization Other more economic and feasible ways such as community home isolation still need further study.

Key words: Tuberculosis, Infectivity, Hospitalization isolation, Cost, Statistics

Zhang Xiaoqi, Liu Jingyuan, Li Minlu, Qu Zhijun, Tan Weiguo. Analysis of the cost of isolation treatment and the infection of sputum bacteria in 56 patients with smear positive pulmonary tuberculosis[J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(1): 28-31.

References

[1] 陈凡,朱荣生,周菁,等.我国结核病防治现状与展望[J].公共卫生与预防医学,2019,30(4):8-11.
[2] World Health Organization.Policy on TB infection control in health care facilities,congregate settings control and house-holds[J].Genava:World Health Organization,2009.
[3] World Health Organization.Implementing the WHO stop TB strategy:a handbook for national tuberculosis control programmes[J].Genava:World Health Organization,2009
[4] 冼翠平,陈小华,许卓卫,等.影响初治菌阳肺结核病人强化期痰菌阴转因素研究[J].中国防痨杂志, 2008, 30(1):7-10.
[5] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断标准(WS 288—2017)[J].新发传染病电子杂志,2018,3(1):59-61.
[6] 邓琪,肖春玲.新型抗结核药物研究进展[J].中国新药杂志,2019,28(13):1567-1573.
[7] 陈昕昶,陈嘉臻,张文宏.抗结核药物及其耐药相关突变位点的研究进展[J].微生物与感染,2019,14(2):106-112.
[8] 侯婧,刘刚,韩莙,等.涂阳肺结核患者243例耐药特征分析[J].中国医药,2019,14(2):222-225.
[9] 刘益萍,庞慧,万康林,等.127株结核分枝杆菌基因分型及耐药相关研究[J].中国人兽共患病学报,2018,34(12):1119-1125.
[10] 何方,张弘,梁瑞英,等.北京市朝阳区涂阳肺结核患者住院隔离治疗的影响因素研究[J].中国防痨杂志,2015,37(4):385—388.
[11] 王娜,王黎霞,李仁忠.四地市结核病定点医院住院初治涂阳肺结核患者医疗费用及经济负担分析[J].中国防痨杂志,2012,34(2):79—83.
[12] 杜义祥,南晶,谢红,等.初治涂阳培阳肺结核患者住院隔离治疗费用和治疗效果分析.中国防痨杂志,2016,38(11):1000-1002.
[13] 严碧涯,端木宏谨.结核病学[M].北京:北京出版社,2003:79.
[14] 郭建琼,严晓峰,杨松. 痰涂阳和涂阴肺结核的危险因素、症状及其并发症的比较研究[J]. 新发传染病电子杂志, 2017, 2(1):22-24.
[15] 杨松,严晓峰.结核病与糖尿病:相互关系和诊治的研究新进展[J].新发传染病电子杂志,2018,3(4):234-238.
[16] 余卫业,谭卫国,罗一婷,等. 2018WHO全球结核报告:全球与中国关键数据分析[J].新发传染病电子杂志,2018,3(4):228-233.